EPO and cancer: Additionally, the analysis of recombinant human erythropoietin (rh-Epo)/liposome interactions [65] showed that small molecule inhibitors (SMI) bound to Tissue transglutaminase (TG2) potently inhibited cancer cell adhesion [66].